CMS expected to cancel clinical signature requirement before implementation date

Article Overview

This article covers a Medicare policy development affecting clinical laboratory orders and the anticipated CMS response to objections from physician, laboratory, and practice-management groups. It is relevant to billing, compliance, and laboratory administration professionals who track federal rulemaking and operational impacts on ordering workflows. The piece focuses on the status of the requirement, statements from industry organizations, and the broader advocacy effort surrounding the policy.